Bringing high-quality and high-added-valued medicines to patients around the world

At Towa International, we work to research, develop, manufacture, and market, generic and value-added medicines to patients around the world.

Our
Ikigai

We contribute to people’s health

We are dedicated to people’s genuine smiles

Our
Activity

We research, develop, manufacture, and market complex generics

and value-added medicines for patients around the world.

 

Discover more

1st Japanese

generic, value-added medicines, and OTC company in Europe.

+0M

in sales

+0

employees

+0

products

About
Us

Our journey begins in 1951 when Towa Pharmaceutical was founded in Osaka – a family-run pharmaceutical company that specializes in the manufacture of therapeutic solutions in Japan.

In 2020 Towa Pharmaceutical became international by adding Towa International business, and we became its major company who operates worldwide within a platform of an R&D center, innovative production capabilities, and direct commercial presence in Europe and the United States of America.

We are building a global business to provide patients around the world with high-quality and high added– value medicines and to support the sustainability of health systems.

Discover more

Our story together

TOWA
PHARMACEUTICAL

TOWA
INTERNATIONAL

1951

Towa Pharmaceutical was originally founded as a family-run business

1989

Pensa originates from PPI expertise and a non-infringement formulation of Omeprazole

1992

Contruction of Martorelles (Barcelona) manufacturing and R&D facilities

1998

Osaka Research Center and Osaka Distribution Center are constructed at Osaka, Japan

2004

Towa was listed on Tokio’s stock exchange.

2022

Internationalization process entering South America and Middle East though licenses and strategic alliances.

International
presence

Our business

Towa US.
Breckenridge Pharmaceutical.
The US.

Breckenridge markets and distributes branded, high-quality, cost-effective generic pharmaceuticals in the United States, under an own-label distribution model.

We act as a trusted pharmaceutical partner, offering our development and manufacturing partners a unique opportunity to reach the US market.

Towa EU.
Towa Pharmaceutical.
Europe.

In 2022, we changed the name of our three commercial affiliates, being now: Towa Pharmaceutical.

We are still operating with our commercial brands, Pensa and ToLife, and planning to do a voluntary and slow transition for the benefit of our patients.

Towa 2B.
B2B.
Worldwide.

We operate worldwide, being present in more than 30 countries.

We want the largest partners in the world to contribute to high-value-added therapeutic solutions to improve people’s life.

Our presence

Towa International’s headquarters are situated in Barcelona, housing the R&D center, an innovative state-of-art center production facility, corporate services, and a sales team. We are also in Italy, Portugal, Germany, Sweden, and the US. From these locations, and through strategic alliances, we reach patients in more than 30 countries.